170 related articles for article (PubMed ID: 30362589)
1. Evaluation of dynamic testing for pituitary pars intermedia dysfunction diagnosis in donkeys.
Mejia-Pereira S; Perez-Ecija A; Buchanan BR; Toribio RE; Mendoza FJ
Equine Vet J; 2019 Jul; 51(4):481-488. PubMed ID: 30362589
[TBL] [Abstract][Full Text] [Related]
2. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
Beech J; Boston R; Lindborg S; Russell GE
J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
[TBL] [Abstract][Full Text] [Related]
3. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.
Menzies-Gow NJ; Banse HE; Duff A; Hart N; Ireland JL; Knowles EJ; McFarlane D; Rendle D
Equine Vet J; 2024 Mar; 56(2):220-242. PubMed ID: 37795557
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of seasonal influences on adrenocorticotropic hormone response to the thyrotropin-releasing hormone stimulation test and its accuracy for diagnosis of pituitary pars intermedia dysfunction.
Adams AA; Siard-Altman MH; Reedy SE; Barker D; Elzinga S; Sanz MG; Urschel K; Ireland JL
Vet J; 2023; 300-302():106035. PubMed ID: 37802466
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
Horn R; Bertin FR
J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.
Beech J; Boston R; Lindborg S
J Vet Intern Med; 2011; 25(6):1431-8. PubMed ID: 22092639
[TBL] [Abstract][Full Text] [Related]
7. The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.
Hu K; Stewart AJ; Yuen KY; Hinrichsen S; Dryburgh EL; Bertin FR
J Vet Intern Med; 2020 May; 34(3):1350-1356. PubMed ID: 32255541
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of imprecise sampling time for 10- and 30-min thyrotropin-releasing hormone stimulation tests in horses.
Vorster DM; Wang W; Kemp KL; Bamford NJ; Bertin FR
Equine Vet J; 2024 Mar; 56(2):291-298. PubMed ID: 37649416
[TBL] [Abstract][Full Text] [Related]
9. Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses.
Kam YN; McKenzie K; Coyle M; Bertin FR
J Vet Intern Med; 2021 Nov; 35(6):2885-2890. PubMed ID: 34642962
[TBL] [Abstract][Full Text] [Related]
10. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
McFarlane D; Beech J; Cribb A
Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses.
Horn R; Stewart AJ; Jackson KV; Dryburgh EL; Medina-Torres CE; Bertin FR
J Vet Intern Med; 2021 Jan; 35(1):560-570. PubMed ID: 33368633
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of equine pituitary pars intermedia dysfunction.
Stewart AJ; Ireland JL; Durham AE; McGowan CM
Vet J; 2023; 300-302():106036. PubMed ID: 37805159
[TBL] [Abstract][Full Text] [Related]
13. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction.
Rendle DI; Litchfield E; Heller J; Hughes KJ
Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059
[TBL] [Abstract][Full Text] [Related]
14. Effect of dietary carbohydrates and time of year on ACTH and cortisol concentrations in adult and aged horses.
Jacob SI; Geor RJ; Weber PSD; Harris PA; McCue ME
Domest Anim Endocrinol; 2018 Apr; 63():15-22. PubMed ID: 29195115
[TBL] [Abstract][Full Text] [Related]
15. Circannual variability in adrenocorticotropic hormone responses to administration of thyrotropin-releasing hormone in clinically normal horses in Australia.
Byrne DP; Secombe CJ; Tan RHH; Perera DI; Watts SP; Wearn JG
Vet J; 2018 Aug; 238():58-62. PubMed ID: 30103916
[TBL] [Abstract][Full Text] [Related]
16. Impact of blue light therapy on plasma adrenocorticotropic hormone (ACTH) and hypertrichosis in horses with pituitary pars intermedia dysfunction.
Miller AB; Murphy BA; Adams AA
Domest Anim Endocrinol; 2022 Jan; 78():106651. PubMed ID: 34656964
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Hormone and Thyrotropin Concentrations and Responses to Thyrotropin-Stimulating Hormone in Horses with PPID Compared with Age-Matched Normal Horses.
Breuhaus BA
J Equine Vet Sci; 2019 Apr; 75():35-40. PubMed ID: 31002090
[TBL] [Abstract][Full Text] [Related]
18. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
Copas VE; Durham AE
Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
[TBL] [Abstract][Full Text] [Related]
19. Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses.
Miller AB; Loynachan AT; Bush HM; Hart KA; Barker VD; Campana-Emard AG; Grubbs ST; Adams AA
Domest Anim Endocrinol; 2021 Jan; 74():106531. PubMed ID: 32942194
[TBL] [Abstract][Full Text] [Related]
20. Pituitary Pars Intermedia Dysfunction and Metabolic Syndrome in Donkeys.
Gehlen H; Schwarz B; Bartmann C; Gernhardt J; Stöckle SD
Animals (Basel); 2020 Dec; 10(12):. PubMed ID: 33302557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
